4//SEC Filing
Thye Dirk 4
Accession 0001415889-24-022702
CIK 0001662774other
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 5:38 PM ET
Size
6.9 KB
Accession
0001415889-24-022702
Insider Transaction Report
Form 4
Thye Dirk
DirectorCEO and CMO
Transactions
- Purchase
Common Stock
2024-08-30$0.70/sh+77,000$53,900→ 843,941 total - Purchase
Common Stock
2024-08-29$0.69/sh+77,500$53,475→ 766,941 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.66 to $0.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.67 to $0.72, inclusive.
Documents
Issuer
Quince Therapeutics, Inc.
CIK 0001662774
Entity typeother
Related Parties
1- filerCIK 0001638945
Filing Metadata
- Form type
- 4
- Filed
- Sep 2, 8:00 PM ET
- Accepted
- Sep 3, 5:38 PM ET
- Size
- 6.9 KB